Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple-negative Breast Cancer: a New Perspective on Predictive and Prognostic Biomarkers

NCT03539965 is registered in ClinicalTrials.gov with Instituto Nacional de Cancer, Brazil as lead sponsor.

NCT NCT03539965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03539965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple-negative Breast Cancer: a New Perspective on Predictive and Prognostic Biomarkers
Lead sponsor
Instituto Nacional de Cancer, Brazil
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
December 31, 2014
Enrollment
239 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancer, triple negative breast neoplasms